Abstract:Structural variation detection remains an elusive undertaking. For decades, G-banded karyotyping has remained the standard practice for nearly all hematological malignancy samples. Cancers are diseases of the genome and structural variants (SVs) are a hallmark of nearly all cancers, are often drivers of oncogenicity, and can sometimes be targeted for treatment, as highlighted by the discovery of the Philadelphia chromosome and later the development of targeted kinase inhibitors. One of the most important limitations of karyotyping, its requirement for cells to divide in culture, has prevented its application for most solid tumors and therefore, there is considerably less understanding of the impact of SVs in solid tumors. Optical genome mapping is a technique that is revolutionizing cytogenomics and unlocking the understanding of SVs in the genome at a level never seen before. It not only can detect nearly all variants that a karyotype can, but it can provide 10,000x higher resolution and does not require cell culture. Because of this, it is being adopted for oncology studies across hematological malignancies and solid tumors. This study demonstrates the performance of a new high throughput Stratys instrument for generation of optical genome map data at extraordinarily high coverage depth. With this instrument, 12 samples can be loaded at once, each loaded onto its own cartridge and the instrument can collect 400x genome coverage for each of these samples in 24 hours. The instrument has random access to the cartridges so that completed samples can be swapped out to facilitate optimal instrument run efficiency. To date, this system has been demonstrated to run 60 samples in a week, each at 400x coverage. Data from the instrument can be processed by Bionano AccessTM and VIATM software to call SVs, copy number variants (CNVs), regions of loss of heterozygosity (LOH), on a genome wide basis, and to classify those variants automatically according to guidelines such as the National Comprehensive Cancer Network (NCCN), World Health Organization (WHO), and National Health Services (NHS, United Kingdom). This new high throughput system with advanced bioinformatic data analysis has the potential to further transform structural variation analysis in cancer research. Citation Format: Alex R. Hastie, Pat Lynch. Genome wide, high-throughput, high-resolution structural variation detection at low variant allele fraction for oncology samples [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6257.

A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis

A powerful random forest-based pipeline for accurately identifying the structural variants on panel sequencing data.

Systematic assessment of structural variant annotation tools for genomic interpretation

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard

Integrative detection and analysis of structural variation in cancer genomes

Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies

The benefit of a complete reference genome for cancer structural variant analysis

Hidden Biases in Germline Structural Variant Detection.

Comprehensive evaluation and characterisation of short read general-purpose structural variant calling software

An Integrative Framework for Detecting Structural Variations in Cancer Genomes

FocalSV: target region-based structural variant assembly and refinement using single-molecule long read sequencing data

Comprehensive Evaluation of Structural Variant Genotyping Methods Based on Long-Read Sequencing Data.

Abstract 6257: Genome wide, high-throughput, high-resolution structural variation detection at low variant allele fraction for oncology samples

A clinically feasible algorithm for the parallel detection of glioma-associated copy number variation markers based on shallow whole genome sequencing

Benchmarking of Germline Copy Number Variant Callers from Whole Genome Sequencing Data for Clinical Applications

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA

SVcnn: an Accurate Deep Learning-Based Method for Detecting Structural Variation Based on Long-Read Data

Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients

Tradeoffs in alignment and assembly-based methods for structural variant detection with long-read sequencing data